Balyasny Asset Management
MTEM

Balyasny Asset Management’s Molecular Templates, Inc. MTEM Stock Holding History

Balyasny Asset Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,630
Closed -$18K – 3371
2022
Q3 		$18K Buy
+1,630
New +$20.5K ﹤0.01% 2595
2015
Q4 		– Sell
-247
Closed -$166K – 1507
2015
Q3 		$166K Buy
+247
New +$176K ﹤0.01% 1025

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Balyasny Asset Management's MTEM Position: Q4 2022 in Review

Balyasny Asset Management sold out of Molecular Templates, Inc. (MTEM) in Q4 2022, closing a stake of 1,630 shares — an estimated $18K sold.

Balyasny Asset Management first reported a position in MTEM in Q3 2015 and held it in 2 quarters. The position peaked at $166K in Q3 2015. 50 funds tracked by Wall St. Rank hold MTEM as of Q4 2022.

  • Balyasny Asset Management reported no remaining Molecular Templates, Inc. position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 1,630 Molecular Templates, Inc. shares in Q4 2022, an estimated $18K.
  • Balyasny Asset Management first reported a position in Molecular Templates, Inc. in Q3 2015 and held it in 2 quarters.
  • Balyasny Asset Management's Molecular Templates, Inc. position peaked at $166K in Q3 2015.
  • 50 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.